The Importance of Eosinophils in Personalized Severe Asthma Treatment

Video

Mark S. Forshag, MD, MHA, GSK, spoke with MD Magazine at AAAAI 2017 in Atlanta, GA, about the importance of eosinophils in treating severe asthma.

Mark S. Forshag, MD, MHA, GSK, spoke with MD Magazine at AAAAI 2017 in Atlanta, Georgia, about the importance of eosinophils in treating severe asthma. Forshag said his team focused on the mass cell and have come to realize there are additional forms of inflammation mediated by the eosinophil cell.

Forshag also shared how phenotypes help identify patients that "are a little different from others". According to Forshag, learning the basis of phenotypes is necessary for understanding the use of the monoclonal antibody Nucala, which is directed against interleukin 5.

Regarding patient care, Forshag said that in the past there used to be a steady progression of drugs clinicans would try on their patients with asthma, and it was pretty much the same progression of drugs no matter what asthmatic they were. However, now they are trying to break people down into subgroups and use specific druugs based on subgroup.

Related Videos
How Psoriatic Arthritis Presentation, Treatment Has Evolved
Optimizing Diabetes Therapies with New Classifications
Anthony Lembo, MD | Credit: Cleveland Clinic
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Elizabeth Aby, MD | Credit: Minnesota Health Fairview
Prashant Singh, MD | Credit: University of Michigan
Noa Krugliak Cleveland, MD | Credit: University of Chicago
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Ali Rezaie, MD | Credit: X
Should We Reclassify Diabetes Subtypes?
© 2024 MJH Life Sciences

All rights reserved.